DK1283830T3 - Para-amin-substituerede phenylamidglucokinase-aktivatorer - Google Patents
Para-amin-substituerede phenylamidglucokinase-aktivatorerInfo
- Publication number
- DK1283830T3 DK1283830T3 DK01943302T DK01943302T DK1283830T3 DK 1283830 T3 DK1283830 T3 DK 1283830T3 DK 01943302 T DK01943302 T DK 01943302T DK 01943302 T DK01943302 T DK 01943302T DK 1283830 T3 DK1283830 T3 DK 1283830T3
- Authority
- DK
- Denmark
- Prior art keywords
- para
- amine
- glucokinase activators
- substituted phenylamide
- phenylamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20238900P | 2000-05-08 | 2000-05-08 | |
| PCT/EP2001/004859 WO2001085707A1 (en) | 2000-05-08 | 2001-04-30 | Para-amine substituted phenylamide glucokinase activators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1283830T3 true DK1283830T3 (da) | 2008-08-25 |
Family
ID=22749673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01943302T DK1283830T3 (da) | 2000-05-08 | 2001-04-30 | Para-amin-substituerede phenylamidglucokinase-aktivatorer |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1283830B1 (es) |
| JP (1) | JP3971189B2 (es) |
| KR (1) | KR100519826B1 (es) |
| CN (1) | CN1185220C (es) |
| AR (1) | AR030279A1 (es) |
| AT (1) | ATE398611T1 (es) |
| AU (2) | AU6591401A (es) |
| BR (1) | BR0110703A (es) |
| CA (1) | CA2407763C (es) |
| DE (1) | DE60134470D1 (es) |
| DK (1) | DK1283830T3 (es) |
| EC (1) | ECSP014062A (es) |
| ES (1) | ES2307623T3 (es) |
| MX (1) | MXPA02010795A (es) |
| PE (1) | PE20020049A1 (es) |
| PT (1) | PT1283830E (es) |
| UY (1) | UY26695A1 (es) |
| WO (1) | WO2001085707A1 (es) |
| ZA (1) | ZA200208503B (es) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610846B1 (en) | 1999-03-29 | 2003-08-26 | Hoffman-La Roche Inc. | Heteroaromatic glucokinase activators |
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| EP1724270A3 (en) | 2001-07-19 | 2007-01-03 | Pfizer Italia S.r.l. | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| EP1336607A1 (en) * | 2002-02-19 | 2003-08-20 | Novo Nordisk A/S | Amide derivatives as glucokinase activators |
| US6911545B2 (en) | 2001-12-19 | 2005-06-28 | Hoffman-La Roche Inc. | Crystals of glucokinase and methods of growing them |
| US20030171411A1 (en) | 2001-12-21 | 2003-09-11 | Kodra Janos Tibor | Amide derivatives as therapeutic agents |
| KR101124245B1 (ko) | 2002-06-27 | 2012-07-02 | 노보 노르디스크 에이/에스 | 치료제로서 아릴 카르보닐 유도체 |
| WO2004002481A1 (en) | 2002-06-27 | 2004-01-08 | Novo Nordisk A/S | Aryl carbonyl derivatives as therapeutic agents |
| JP2006509774A (ja) * | 2002-10-03 | 2006-03-23 | ノバルティス アクチエンゲゼルシャフト | ２型糖尿病の処置において有用なグルコキナーゼアクチベーターとしての置換（チアゾール−２−イル）−アミドまたはスルホンアミド |
| GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| ATE506354T1 (de) | 2003-01-06 | 2011-05-15 | Lilly Co Eli | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren |
| AU2003294376A1 (en) * | 2003-01-06 | 2004-08-10 | Eli Lilly And Company | Heteroaryl compounds |
| PL378117A1 (pl) | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tricyklopodstawione związki amidowe |
| MXPA06007667A (es) | 2004-01-06 | 2006-09-01 | Novo Nordisk As | Heteroaril-ureas y su uso como activadores de glucocinasa. |
| ATE524479T1 (de) * | 2004-04-02 | 2011-09-15 | Novartis Ag | Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren |
| JP2007530631A (ja) | 2004-04-02 | 2007-11-01 | ノバルティス アクチエンゲゼルシャフト | チアゾロピリジン誘導体、それを含む医薬組成物およびグルコキナーゼ介在性状態の処置法 |
| JP2008521864A (ja) | 2004-12-03 | 2008-06-26 | トランステック・ファーマ、インコーポレイテッド | ヘテロ芳香族グルコキナーゼ活性化剤 |
| JP2009500377A (ja) | 2005-07-08 | 2009-01-08 | ノボ・ノルデイスク・エー／エス | ジシクロアルキルウレア型グルコキナーゼ活性化剤 |
| NZ575512A (en) | 2005-07-09 | 2009-11-27 | Astrazeneca Ab | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| WO2007015805A1 (en) | 2005-07-20 | 2007-02-08 | Eli Lilly And Company | 1-amino linked compounds |
| BRPI0615236A2 (pt) | 2005-08-31 | 2011-05-10 | Astellas Pharma Inc | derivado de tiazol |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| EP1931337B1 (en) | 2005-09-29 | 2013-10-23 | Sanofi | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| GT200600428A (es) | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
| GT200600429A (es) | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
| DK1951658T3 (da) | 2005-11-17 | 2012-10-15 | Lilly Co Eli | Glucagonreceptorantagonister, fremstilling og terapeutiske anvendelser |
| JP5302012B2 (ja) | 2006-03-08 | 2013-10-02 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤 |
| US8211925B2 (en) | 2006-04-28 | 2012-07-03 | Transtech Pharma, Inc. | Benzamide glucokinase activators |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| JP5386350B2 (ja) | 2006-05-31 | 2014-01-15 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体 |
| AU2007278261A1 (en) | 2006-07-24 | 2008-01-31 | F. Hoffmann-La Roche Ag | Pyrazoles as glucokinase activators |
| WO2008079787A2 (en) | 2006-12-20 | 2008-07-03 | Takeda San Diego, Inc. | Glucokinase activators |
| TW200831081A (en) | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
| CN101622231B (zh) | 2007-02-28 | 2013-12-04 | 艾德维纳斯医疗私人有限公司 | 作为葡糖激酶激活剂的2，2，2-三取代的乙酰胺衍生物、它们的制造方法和药学应用 |
| US8173645B2 (en) | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
| EP2157090A4 (en) | 2007-06-21 | 2011-09-07 | Taisho Pharmaceutical Co Ltd | PYRAZINAMIDE COMPOUND |
| MX2010007853A (es) | 2008-01-18 | 2010-10-06 | Astellas Pharma Inc | Derivado de fenilacetamida. |
| US8258134B2 (en) | 2008-04-16 | 2012-09-04 | Hoffmann-La Roche Inc. | Pyridazinone glucokinase activators |
| US7741327B2 (en) | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
| MX2010011778A (es) | 2008-04-28 | 2010-11-30 | Kyorin Seiyaku Kk | Derivados de ciclopentil acrilamida. |
| MY152749A (en) | 2008-05-16 | 2014-11-28 | Takeda California Inc | Pyrazole and fused pyrazole glucokinase activators |
| UA104742C2 (uk) | 2008-12-19 | 2014-03-11 | Эли Лилли Энд Компани | Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази |
| RU2551847C2 (ru) | 2009-12-04 | 2015-05-27 | Тайсо Фармасьютикал Ко., Лтд. | Производные 2-пиридона |
| US8222416B2 (en) | 2009-12-14 | 2012-07-17 | Hoffmann-La Roche Inc. | Azaindole glucokinase activators |
| AU2011235212B2 (en) | 2010-03-31 | 2014-07-31 | The Scripps Research Institute | Reprogramming cells |
| US8877794B2 (en) * | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| EP4487909A3 (en) | 2018-06-12 | 2025-03-19 | vTv Therapeutics LLC | Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs |
| US12391658B2 (en) | 2020-02-18 | 2025-08-19 | Vtv Therapeutics Llc | Sulfoxide and sulfone glucokinase activators and methods of use thereof |
| CA3181722A1 (en) | 2020-06-08 | 2021-12-16 | Jing TENG | Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4317320A1 (de) * | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | Neue Thiazolidindione und diese enthaltende Arzneimittel |
| US6011048A (en) * | 1997-01-28 | 2000-01-04 | Merck & Co., Inc. | Thiazole benzenesulfonamides as β3 agonists for treatment of diabetes and obesity |
-
2001
- 2001-04-30 MX MXPA02010795A patent/MXPA02010795A/es active IP Right Grant
- 2001-04-30 EP EP01943302A patent/EP1283830B1/en not_active Expired - Lifetime
- 2001-04-30 CA CA002407763A patent/CA2407763C/en not_active Expired - Fee Related
- 2001-04-30 AU AU6591401A patent/AU6591401A/xx active Pending
- 2001-04-30 AT AT01943302T patent/ATE398611T1/de not_active IP Right Cessation
- 2001-04-30 WO PCT/EP2001/004859 patent/WO2001085707A1/en not_active Ceased
- 2001-04-30 AU AU2001265914A patent/AU2001265914B2/en not_active Ceased
- 2001-04-30 PT PT01943302T patent/PT1283830E/pt unknown
- 2001-04-30 CN CNB018092233A patent/CN1185220C/zh not_active Expired - Fee Related
- 2001-04-30 JP JP2001582308A patent/JP3971189B2/ja not_active Expired - Fee Related
- 2001-04-30 BR BR0110703-8A patent/BR0110703A/pt not_active IP Right Cessation
- 2001-04-30 DE DE60134470T patent/DE60134470D1/de not_active Expired - Lifetime
- 2001-04-30 DK DK01943302T patent/DK1283830T3/da active
- 2001-04-30 ES ES01943302T patent/ES2307623T3/es not_active Expired - Lifetime
- 2001-04-30 KR KR10-2002-7014921A patent/KR100519826B1/ko not_active Expired - Fee Related
- 2001-05-02 PE PE2001000395A patent/PE20020049A1/es not_active Application Discontinuation
- 2001-05-04 AR ARP010102124A patent/AR030279A1/es unknown
- 2001-05-07 UY UY26695A patent/UY26695A1/es not_active Application Discontinuation
- 2001-05-08 EC EC2001004062A patent/ECSP014062A/es unknown
-
2002
- 2002-10-21 ZA ZA200208503A patent/ZA200208503B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001085707A1 (en) | 2001-11-15 |
| EP1283830B1 (en) | 2008-06-18 |
| CA2407763A1 (en) | 2001-11-15 |
| ES2307623T3 (es) | 2008-12-01 |
| ATE398611T1 (de) | 2008-07-15 |
| CN1185220C (zh) | 2005-01-19 |
| BR0110703A (pt) | 2003-01-28 |
| AR030279A1 (es) | 2003-08-20 |
| KR20020094019A (ko) | 2002-12-16 |
| JP3971189B2 (ja) | 2007-09-05 |
| AU2001265914B2 (en) | 2005-11-03 |
| ECSP014062A (es) | 2002-02-25 |
| PT1283830E (pt) | 2008-08-18 |
| EP1283830A1 (en) | 2003-02-19 |
| AU6591401A (en) | 2001-11-20 |
| UY26695A1 (es) | 2001-11-30 |
| DE60134470D1 (de) | 2008-07-31 |
| PE20020049A1 (es) | 2002-02-01 |
| JP2003532719A (ja) | 2003-11-05 |
| CA2407763C (en) | 2007-04-24 |
| CN1427830A (zh) | 2003-07-02 |
| MXPA02010795A (es) | 2003-03-27 |
| ZA200208503B (en) | 2004-01-22 |
| KR100519826B1 (ko) | 2005-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1283830T3 (da) | Para-amin-substituerede phenylamidglucokinase-aktivatorer | |
| DK1280801T3 (da) | Hydantoinholdige glucokinaseaktivatorer | |
| DK1169312T3 (da) | Glucokinaseaktivatorer | |
| DK1242397T3 (da) | Trans-olefiniske glucokinaseaktivatorer | |
| ATE297921T1 (de) | Tetrazolylphenyl-acetamide als glukokinaseaktivatoren | |
| DE50104655D1 (de) | Leiterplattensteckverbinder | |
| DE60000964D1 (de) | Glaskeramik | |
| DE50105915D1 (de) | Schutzhülle | |
| DE60104745D1 (de) | Absorbierender Artikel | |
| ATE286702T1 (de) | Absorbierender artikel | |
| DE60133432D1 (de) | Biomaterial | |
| DE60122834D1 (de) | Torsions-Kipp-Komponente | |
| DE50113112D1 (de) | Schaltungsanordnung | |
| DE50105875D1 (de) | Bauteil | |
| DE60107757D1 (de) | Leiterplattensteckverbinder | |
| DE60139439D1 (de) | LC-integriertes elektronisches Bauteil | |
| DE60115571D1 (de) | Vorwärtsgekoppelte Linearisierer | |
| DE50115426D1 (de) | Schaltungsanordnung | |
| DE50107699D1 (de) | Bauelement | |
| ATA12432000A (de) | Bauelement | |
| SE0002026D0 (sv) | Stödbräda | |
| ITRM20000220A1 (it) | Cinnamilidenidrazide isonicotinica c15h13n3o | |
| DK1282612T3 (da) | Heteroaromatiske alkylphenyl-glucokinaseaktivatorer | |
| NO20005602D0 (no) | Spesialbord | |
| ATA14512002A (de) | Flächiges bauelement |